A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial of Reldesemtiv in Patients with ALS

Amyotroph Lateral Scler Frontotemporal Degener • May 22, 2022July 13, 2022

Shefner JM, Andrews JA, Genge A, Jackson C, Lechtzin N, Miller TM, et al.